49 results on '"Adelstein, David J."'
Search Results
2. Prospective Clinical Study of Precision Oncology in Solid Tumors
3. Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus–negative head and neck cancer
4. Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx
5. Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: Impact of changing disease epidemiology on contemporary trial design
6. Effect of Human Papillomavirus on Patterns of Distant Metastatic Failure in Oropharyngeal Squamous Cell Carcinoma Treated With Chemoradiotherapy
7. A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction
8. Solitary dural metastasis at presentation in a patient with untreated human papillomavirus–associated squamous cell carcinoma of the oropharynx
9. In squamous cell head and neck cancer: which platinum, how much and how often?
10. Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia
11. Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck
12. Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly†‡
13. A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction
14. Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization
15. A Phase II Study of Perioperative Concurrent Chemotherapy, Gefitinib, and Hyperfractionated Radiation Followed by Maintenance Gefitinib in Locoregionally Advanced Esophagus and Gastroesophageal Junction Cancer
16. DOCETAXEL, CISPLATIN, AND FLUOROURACIL INDUCTION CHEMOTHERAPY FOLLOWED BY ACCELERATED FRACTIONATION/CONCOMITANT BOOST RADIATION AND CONCURRENT CISPLATIN IN PATIENTS WITH ADVANCED SQUAMOUS CELL HEAD AND NECK CANCER: A SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0216)#
17. Mature Results from a Phase II Trial of Postoperative Concurrent Chemoradiotherapy for Poor Prognosis Cancer of the Esophagus and Gastroesophageal Junction
18. Induction Chemoradiotherapy Increases Pleural and Pericardial Complications after Esophagectomy for Cancer
19. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy
20. Role of 18F-FDG PET in Management of Sinonasal Neoplasms
21. Choice of Radiotherapy Planning Modality Influences Toxicity in the Treatment of Locally Advanced Esophageal Cancer
22. Choice of Radiotherapy Planning Modality Influences Toxicity in the Treatment of Locally Advanced Esophageal Cancer
23. Ability of Positron Emission Tomography to Detect Residual Neck Node Disease in Patients With Head and Neck Squamous Cell Carcinoma After Definitive Chemoradiotherapy
24. American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
25. Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer?
26. Multiagent Concurrent Chemoradiotherapy for Locoregionally Advanced Squamous Cell Head and Neck Cancer: Mature Results From a Single Institution
27. Induction Redux: Once More With Taxanes
28. Impact of Induction Concurrent Chemoradiotherapy on Pulmonary Function and Postoperative Acute Respiratory Complications in Esophageal Cancer*
29. Endoscopic Ultrasound Errors in Esophageal Cancer
30. Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial
31. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma
32. Chemoradiotherapy in Unresectable Squamous Cell Head and Neck Cancer: In Reply
33. Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer
34. Refining esophageal cancer staging
35. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma
36. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
37. Stage III non–small cell lung cancer and metachronous brain metastases
38. Maximizing Local Control and Organ Preservation in Stage IV Squamous Cell Head and Neck Cancer With Hyperfractionated Radiation and Concurrent Chemotherapy
39. Superficial adenocarcinoma of the esophagus
40. Preoperative Chemoradiotherapy Using Taxanes for Locally Advanced Esophageal Carcinoma
41. N1 esophageal carcinoma: The importance of staging and downstaging
42. Does Paclitaxel Improve the Chemoradiotherapy of Locoregionally Advanced Esophageal Cancer? A Nonrandomized Comparison With Fluorouracil-Based Therapy
43. M1A/M1B ESOPHAGEAL CARCINOMA: CLINICAL RELEVANCE
44. Aggressive Concurrent Chemoradiotherapy for Squamous Cell Head and Neck Cancer: An 8-Year Single-Institution Experience
45. T2N0M0 esophageal cancer
46. Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma
47. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer
48. Comparison of Surgical Complications After Organ-Preservation Therapy in Patients With Stage III or IV Squamous Cell Head and Neck Cancer
49. STAGE II ESOPHAGEAL CARCINOMA: THE SIGNIFICANCE OF T AND N
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.